Latest Embryonic stem cell Stories
Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates.
- Tuesday, July 29, 2014, at 4:30 p.m. EDT, 1:30 p.m. PDT - MENLO PARK, Calif., July 24, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc.
researchers have found a gene that could be key to the development of stem cells – cells that can potentially save millions of lives by morphing into practically any cell in the body.
According to a new report from BCC Research, the global market for induced pluripotent stem cells (iPSCs) is expected to grow to $2.9 billion by 2018, with a five-year compound annual growth rate
SAN DIEGO, July 17, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, today announced that
EWING, N.J., July 16, 2014 /PRNewswire/ -- Essential Pharmaceuticals LLC, Ewing NJ announces the release of Cell-Ess® serum replacement for cell culture.
Accepted to stem cell treatment, but insurance won't cover it POLLOCK PINES, Calif., July 15, 2014 /PRNewswire/ -- Marc Serchia, 56, is waiting on a miracle, and if the doctors are
The pluripotency factor NANOG regulates cell proliferation in epithelia of the skin and oesophagus in adult organisms; blocking the action of the gene diminishes the capacity of tumour cells to divide
LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- A woman chauffeur.
- A woman who operates an automobile.
More Images (3 images) »